AVDL
Price:
$14.49
Market Cap:
$1.39B
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1996-06-07
Stock Exchange
NASDAQ
Ticker
AVDL
According to Avadel Pharmaceuticals plc’s latest financial reports and current stock price. The company's current Enterprise Value is 1.40B. This represents a change of 9.38% compared to the average of 1.28B of the last 4 quarters.
The mean historical Enterprise Value of Avadel Pharmaceuticals plc over the last ten years is 504.00M. The current 1.40B Enterprise Value has changed 27.75% with respect to the historical average. Over the past ten years (40 quarters), AVDL's Enterprise Value was at its highest in in the March 2024 quarter at 1.53B. The Enterprise Value was at its lowest in in the September 2015 quarter at 0.
Average
504.00M
Median
422.18M
Minimum
202.81M
Maximum
1.14B
Discovering the peaks and valleys of Avadel Pharmaceuticals plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 146.45%
Maximum Annual Enterprise Value = 1.14B
Minimum Annual Increase = -38.27%
Minimum Annual Enterprise Value = 202.81M
Year | Enterprise Value | Change |
---|---|---|
2023 | 1.14B | 133.17% |
2022 | 487.31M | -14.09% |
2021 | 567.26M | 37.41% |
2020 | 412.82M | 3.91% |
2019 | 397.27M | 95.88% |
2018 | 202.81M | -35.72% |
2017 | 315.52M | -19.13% |
2016 | 390.17M | -9.59% |
2015 | 431.54M | -38.27% |
2014 | 699.07M | 146.45% |
The current Enterprise Value of Avadel Pharmaceuticals plc (AVDL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
730.28M
5-year avg
600.19M
10-year avg
504.00M
Avadel Pharmaceuticals plc’s Enterprise Value is less than Neurocrine Biosciences, Inc. (12.29B), less than Deciphera Pharmaceuticals, Inc. (2.15B), greater than Ironwood Pharmaceuticals, Inc. (1.26B), less than Alkermes plc (4.26B), less than Intra-Cellular Therapies, Inc. (7.09B), less than Dynavax Technologies Corporation (1.59B), greater than Journey Medical Corporation (95.90M), greater than Evoke Pharma, Inc. (-1007253.00), greater than Jupiter Wellness, Inc. (45.30M), greater than Aquestive Therapeutics, Inc. (407.64M), greater than Eagle Pharmaceuticals, Inc. (110.03M), greater than ANI Pharmaceuticals, Inc. (1.34B), greater than Agile Therapeutics, Inc. (7.87M), greater than Assertio Holdings, Inc. (116.04M), less than Amneal Pharmaceuticals, Inc. (5.28B), greater than AcelRx Pharmaceuticals, Inc. (1.19M), greater than Lifecore Biomedical, Inc. (269.28M),
Company | Enterprise Value | Market cap |
---|---|---|
12.29B | $12.13B | |
2.15B | $2.21B | |
1.26B | $720.42M | |
4.26B | $4.42B | |
7.09B | $7.77B | |
1.59B | $1.45B | |
95.90M | $97.00M | |
-1007253.00 | $3.17M | |
45.30M | $49.33M | |
407.64M | $380.63M | |
110.03M | $55.19M | |
1.34B | $1.27B | |
7.87M | $10.43M | |
116.04M | $120.12M | |
5.28B | $2.60B | |
1.19M | $14.58M | |
269.28M | $147.38M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avadel Pharmaceuticals plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Avadel Pharmaceuticals plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Avadel Pharmaceuticals plc's Enterprise Value?
What is the highest Enterprise Value for Avadel Pharmaceuticals plc (AVDL)?
What is the 3-year average Enterprise Value for Avadel Pharmaceuticals plc (AVDL)?
What is the 5-year average Enterprise Value for Avadel Pharmaceuticals plc (AVDL)?
How does the current Enterprise Value for Avadel Pharmaceuticals plc (AVDL) compare to its historical average?